In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides

References

• Akbuga, J., Durmaz, G. (1994). Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int J Pharm. 111:217–222.
   Web of Science ®Google Scholar
• Akhtar, S., Hughes, M.D., Khan, A., Bibby, M., Hussain, M., Nawaz, Q., Double, J., Sayyed, P. (2000). The delivery of antisense therapeutics. Adv Drug Deliv Rev. 44:3–21.
   PubMed Web of Science ®Google Scholar
• Aukunuru, J.V., Ayalasomayajula, S.P., Kompella, U.B. (2003). Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells. J Pharm Pharmacol. 55:1199–1206.
   PubMed Web of Science ®Google Scholar
• Blanco, D., Alonso, M.J. (1998). Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm. 45:285–294.
   PubMed Web of Science ®Google Scholar
• Budhian, A., Siegel, S.J., Winey, K.I. (2008). Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm. 346:151–159.
   PubMed Web of Science ®Google Scholar
• Chang, C.Y., Laux-Fenton, W.T., Law, L.Y., Becker, D.L., Sherwin, T., Green, C.R. (2009). Antisense down regulation of connexin31.1 reduces apoptosis and increases thickness of human and animal corneal epithelia. Cell Biol Int. 33:376–385.
   PubMed Web of Science ®Google Scholar
• Chen, X., Dudgeon, N., Shen, L., Wang, J.H. (2005). Chemical modification of gene silencing oligonucleotides for drug discovery and development. Drug Discov Today. 10:587–593.
   PubMed Web of Science ®Google Scholar
• Cheng, F.Y., Wang, S.P., Su, C.H., Tsai, T.L., Wu, P.C., Shieh, D.B., Chen, J.H., Hsieh, P.C., Yeh, C.S. (2008). Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. Biomaterials. 29:2104–2112.
   PubMed Web of Science ®Google Scholar
• Costa, P., Sousa Lobo, J.M. (2001). Modelling and comparison of dissolution profiles. Eur J Pharm Sci. 13:123–133.
   PubMed Web of Science ®Google Scholar
• Crooke, S.T. (1998). Molecular mechanisms of antisense drugs: RNase H. Antisense Nucleic Acid Drug Dev. 8:133–134.
   PubMedGoogle Scholar
• Dokka, S., Rojanasakul, Y. (2000). Novel non-endocytic delivery of antisense oligonucleotides. Adv Drug Deliv Rev. 44:35–49.
   PubMed Web of Science ®Google Scholar
• Elamanchili, P., (2007). Antigen delivery to dendritic cells using biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles. University of Alberta, Canada.
   Google Scholar
• Fattal, E., Bochot, A. (2008). State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int J Pharm. 364:237–248.
   PubMed Web of Science ®Google Scholar
• Foster, K.A., Yazdanian, M., Audus, K.L. (2001). Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol. 53:57–66.
   PubMed Web of Science ®Google Scholar
• Goliger, J.A., Paul, D.L. (1994). Expression of gap junction proteins Cx26, Cx31.1, Cx37, and Cx43 in developing and mature rat epidermis. Dev Dyn. 200:1–13.
   PubMed Web of Science ®Google Scholar
• Hennemann, H., Dahl, E., White, J.B., Schwarz, H.J., Lalley, P.A., Chang, S., Nicholson, B.J., Willecke, K. (1992). Two gap junction genes, connexin 31.1 and 30.3, are closely linked on mouse chromosome 4 and preferentially expressed in skin. J Biol Chem. 267:17225–17233.
   PubMed Web of Science ®Google Scholar
• Higuchi, T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 50:874–875.
   PubMed Web of Science ®Google Scholar
• Hixson, A.W., Crowell, J.H. (2002). Dependence of Reaction Velocity upon Surface and Agitation. Ind Eng Chem. 23:1160–1168.
   Google Scholar
• Labhasetwar, V., Song, C., Levy, R.J. (1997). Nanoparticle drug delivery system for restenosis. Adv Drug Deliv Rev. 24:63–85.
   Web of Science ®Google Scholar
• Leonetti, J.P., Degols, G., Clarenc, J.P., Mechti, N., Lebleu, B. (1993). Cell delivery and mechanisms of action of antisense oligonucleotides. Prog Nucleic Acid Res Mol Biol. 44:143–166.
   PubMed Web of Science ®Google Scholar
• Li, S., Huang, L. (2000). Nonviral gene therapy: promises and challenges. Gene Ther. 7:31–34.
   PubMed Web of Science ®Google Scholar
• Mainardes, R.M., Evangelista, R.C. (2005). PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 290:137–144.
   PubMed Web of Science ®Google Scholar
• Mukherjee, S., Ghosh, R.N., Maxfield, F.R. (1997). Endocytosis. Physiol Rev. 77:759–803.
   PubMed Web of Science ®Google Scholar
• Nafee, N., Taetz, S., Schneider, M., Schaefer, U.F., Lehr, C.M. (2007). Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomed. 3:173–183.
   PubMed Web of Science ®Google Scholar
• O’Donnell, P.B., McGinity, J.W. (1997). Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev. 28:25–42.
   PubMed Web of Science ®Google Scholar
• Panyam, J., Dali, M.M., Sahoo, S.K., Ma, W., Chakravarthi, S.S., Amidon, G.L., Levy, R.J., Labhasetwar, V. (2003). Polymer degradation and in vitro release of a model protein from poly(,-lactide-co-glycolide) nano- and microparticles. J Control Release. 92:173–187.
   PubMed Web of Science ®Google Scholar
• Panyam, J., Zhou, W.-Z., Prabha, S., Sahoo, S.K., Labhasetwar, V. (2002). Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 16:1217–1226.
   PubMed Web of Science ®Google Scholar
• Prabha, S., Labhasetwar, V. (2004). Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm Res. 21:354–364.
   PubMed Web of Science ®Google Scholar
• Qaddoumi, M.G., Gukasyan, H.J., Davda, J., Labhasetwar, V., Kim, K.J., Lee, V.H. (2003). Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol Vis. 9:559–568.
   PubMed Web of Science ®Google Scholar
• Ravi Kumar, M.N., Bakowsky, U., Lehr, C.M., Ravi Kumar, M.N.V. (2004). Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials. 25:1771–1777.
   PubMed Web of Science ®Google Scholar
• Remaut, K., Symens, N., Lucas, B., Demeester, J., De Smedt, S.C. (2010). Efficient delivery of intact phosphodiester oligonucleotides by poly-[beta]-amino esters. J Control Release. 144:65–74.
   PubMed Web of Science ®Google Scholar
• Rizkalla, N., Range, C., Lacasse, F.X., Hildgen, P. (2006). Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion method. J Microencapsul. 23:39–57.
   PubMed Web of Science ®Google Scholar
• Rupper, A., Cardelli, J. (2001). Regulation of phagocytosis and endo-phagosomal trafficking pathways in Dictyostelium discoideum. Biochim Biophys Acta. 1525:205–216.
   PubMed Web of Science ®Google Scholar
• Song, X., Zhao, Y., Hou, S., Xu, F., Zhao, R., He, J., Cai, Z., Li, Y., Chen, Q. (2008). Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm. 69:445–453.
   PubMed Web of Science ®Google Scholar
• Stein, C.A., Cheng, Y.C. (1993). Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science. 261:1004–1012.
   PubMed Web of Science ®Google Scholar
• Suh, H., Jeong, B., Liu, F., Kim, S.W. (1998). Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells. Pharm Res. 15:1495–1498.
   PubMed Web of Science ®Google Scholar
• Toub, N., Malvy, C., Fattal, E., Couvreur, P. (2006). Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. Biomed Pharmacother. 60:607–620.
   PubMed Web of Science ®Google Scholar
• Zon, G. (1988). Oligonucleotide analogues as potential chemotherapeutic agents. Pharm Res. 5:539–549.
   PubMed Web of Science ®Google Scholar